Back to User profile » Dr Yonghui Hu
Papers published by Dr Yonghui Hu:
Murine Model Insights: Identifying Dusp15 as a Novel Biomarker for Diabetic Cardiomyopathy Uncovered Through Integrated Omics Analysis and Experimental Validation
Zhu L, Dong Y, Guo H, Qiu J, Guo J, Hu Y, Pan C
Diabetes, Metabolic Syndrome and Obesity 2025, 18:515-527
Published Date: 19 February 2025
Intermittent Use of Flash Glucose Monitoring Improves Glycemic Control in Chinese Older Patients with Type 2 Diabetes Mellitus
Hu Y, Yan R, Shen Y, Li H, Ma J, Su X
Diabetes, Metabolic Syndrome and Obesity 2025, 18:1-9
Published Date: 3 January 2025
Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients [Corrigendum]
Hu Y, Yan Z, Pan C
Diabetes, Metabolic Syndrome and Obesity 2024, 17:4387-4388
Published Date: 23 November 2024
Association of Thyroid Hormone Levels with Microvascular Complications in Euthyroid Type 2 Diabetes Mellitus Patients
Hu Y, Hu Z, Tang W, Liu W, Wu X, Pan C
Diabetes, Metabolic Syndrome and Obesity 2022, 15:2467-2477
Published Date: 12 August 2022
Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease
Hu Y, Tang W, Liu W, Hu Z, Pan C
Drug Design, Development and Therapy 2022, 16:1605-1620
Published Date: 31 May 2022
Complement C7 is Specifically Expressed in Mesangial Cells and is a Potential Diagnostic Biomarker for Diabetic Nephropathy and is Regulated by miR-494-3p and miR-574-5p
Guo H, Yan Z, Hu Y, Huang X, Pan C
Diabetes, Metabolic Syndrome and Obesity 2021, 14:3077-3088
Published Date: 5 July 2021
Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
Hu Y, Yan Z, Pan C
Diabetes, Metabolic Syndrome and Obesity 2021, 14:2683-2691
Published Date: 15 June 2021